Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2018	$ 1,128	$ 19,311,529	$ (21,013,174)	$ (1,700,517)
Balance (in shares) at Dec. 31, 2018	3,417,187
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	2,893,658	0	2,893,658
Issuance of common stock, net of issuance costs	$ 16	749,984	0	750,000
Issuance of common stock, net of issuance costs (in shares)	48,930
Issuance of common stock for antidilution	$ 32	(32)	0	0
Issuance of common stock for antidilution (in shares)	97,960
Issuance of common stock for convertible debt	$ 3	32,950	0	32,953
Issuance of common stock for convertible debt (in shares)	9,683
Issuance of common stock from 401K match	$ 2	29,702	0	29,704
Issuance of common stock from 401K match (in shares)	5,258
Issuance of common stock from equity transaction	$ 33	603,891	0	603,924
Issuance of common stock from equity transaction (in shares)	100,654
Equity from merger transaction	$ 528	15,793,110	0	15,793,638
Equity from merger transaction (in shares)	1,599,178
Net loss	$ 0	0	(2,820,763)	(2,820,763)
Balance at Sep. 30, 2019	$ 1,742	39,414,792	(23,833,937)	15,582,597
Balance (in shares) at Sep. 30, 2019	5,278,850
Balance at Jun. 30, 2019	$ 1,709	38,686,233	(18,082,327)	20,605,615
Balance (in shares) at Jun. 30, 2019	5,177,487
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	120,207	0	120,207
Issuance of common stock from 401K match	$ 0	4,461	0	4,461
Issuance of common stock from 401K match (in shares)	709
Issuance of common stock from equity transaction	$ 33	603,891	0	603,924
Issuance of common stock from equity transaction (in shares)	100,654
Net loss	$ 0	0	(5,751,610)	(5,751,610)
Balance at Sep. 30, 2019	$ 1,742	39,414,792	(23,833,937)	15,582,597
Balance (in shares) at Sep. 30, 2019	5,278,850
Balance at Dec. 31, 2019	$ 1,742	40,633,670	(28,937,705)	11,697,707
Balance (in shares) at Dec. 31, 2019	5,281,237
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	300,898	0	300,898
Issuance of common stock, net of issuance costs	$ 5,581	29,750,921	0	29,756,502
Issuance of common stock, net of issuance costs (in shares)	16,900,000
Issuance of common stock for warrant exercise	$ 22	70,437	0	70,459
Issuance of common stock for warrant exercise (in shares)	65,240
Issuance of common stock from 401K match	$ 1	19,966	0	19,967
Issuance of common stock from 401K match (in shares)	15,142
Net loss	$ 0	0	(10,820,574)	(10,820,574)
Balance at Sep. 30, 2020	$ 7,346	70,775,892	(39,758,279)	31,024,959
Balance (in shares) at Sep. 30, 2020	22,261,619
Balance at Jun. 30, 2020	$ 5,064	52,861,882	(35,852,457)	17,014,489
Balance (in shares) at Jun. 30, 2020	15,361,619
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	$ 0	129,792	0	129,792
Issuance of common stock, net of issuance costs	$ 2,282	17,784,218	0	17,786,500
Issuance of common stock, net of issuance costs (in shares)	6,900,000
Issuance of common stock from 401K match	$ 0	0	0	0
Issuance of common stock from 401K match (in shares)	0
Net loss	$ 0	0	(3,905,822)	(3,905,822)
Balance at Sep. 30, 2020	$ 7,346	$ 70,775,892	$ (39,758,279)	$ 31,024,959
Balance (in shares) at Sep. 30, 2020	22,261,619